Key points are not available for this paper at this time.
To the Editor: Artificial intelligence (AI) and machine learning (ML) have the potential to improve and expand access to skin cancer screening. However, some populations may not benefit if technologies are developed with insufficiently diverse datasets.1 US cohorts used to train deep learning algorithms are disproportionately derived from a few states,2 and skin of color and racial/ethnic diversity represented in dermatologic AI applications are not well-characterized. We conducted a scoping review to investigate skin types and populations included in dermatologic ML research.
Guo et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: